Potentiating the activity of nisin against Escherichia coli

Frontiers in Cell and Developmental Biology

Volumn 4, Issue FEB, 2016, Pages

  Zhou, Liang ^a   van Heel, Auke J ^a   Montalban Lopez, Manuel ^a   Kuipers, Oscar P ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Fusion; Gram negative; Lantibiotic; Nisin; Outer membrane

Indexed keywords

EID: 85010612712     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2016.00007     Document Type: Article

References (48)

1. Bauer, R., and Dicks, L. M. T. (2005). Mode of action of lipid II-targeting lantibiotics. Int. J. Food Microbiol. 101, 201-216. doi: 10.1016/j.ijfoodmicro.2004.11.007
2. Berthold, N., Czihal, P., Fritsche, S., Sauer, U., Schiffer, G., Knappe, D., et al. (2013). Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob. Agents Chemother. 57, 402-409. doi: 10.1128/AAC.01923-12
3. Bikker, F. J., Kaman-van Zanten, W. E., de Vries-van de Ruit, A.-M. B. C., Voskamp-Visser, I., van Hooft, P. A. V., Mars-Groenendijk, R. H., et al. (2006). Evaluation of the antibacterial spectrum of drosocin analogues. Chem. Biol. Drug Des. 68, 148-153. doi: 10.1111/j.1747-0285.2006.00424.x
4. Bosma, T., Kanninga, R., Neef, J., Audouy, S. A. L., van Roosmalen, M. L., Steen, A., et al. (2006). Novel surface display system for proteins on non-genetically modified gram-positive bacteria. Appl. Environ. Microbiol. 72, 880-889. doi: 10.1128/AEM.72.1.880-889.2006
5. Boziaris, I. S., and Adams, M. R. (1999). Effect of chelators and nisin produced in situ on inhibition and inactivation of Gram negatives. Int. J. Food Microbiol. 53, 105-113. doi: 10.1016/S0168-1605(99)00139-7
6. Breukink, E., and de Kruijff, B. (2006). Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5, 321-332. doi: 10.1038/nrd2004
7. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O. P., Sahl, H. G., and de Kruijff, B. (1999). Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361-2364
8. Clifton, L. A., Skoda, M. W. A., Le Brun, A. P., Ciesielski, F., Kuzmenko, I., Holt, S. A., et al. (2015). Effect of divalent cation removal on the structure of gram-negative bacterial outer membrane models. Langmuir ACS J. Surf. Colloids 31, 404-412. doi: 10.1021/la504407v
9. Czihal, P., Knappe, D., Fritsche, S., Zahn, M., Berthold, N., Piantavigna, S., et al. (2012). Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens. ACS Chem. Biol. 7, 1281-1291. doi: 10.1021/cb300063v
10. de Ruyter, P. G., Kuipers, O. P., and de Vos, W. M. (1996). Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62, 3662-3667
11. Draper, L. A., Cotter, P. D., Hill, C., and Ross, R. P. (2015). Lantibiotic resistance. Microbiol. Mol. Biol. Rev. 79, 171-191. doi: 10.1128/MMBR.00051-14
12. Erridge, C., Bennett-Guerrero, E., and Poxton, I. R. (2002). Structure and function of lipopolysaccharides. Microbes Infect. 4, 837-851. doi: 10.1016/S1286-4579(02)01604-0
13. Field, D., Begley, M., O'Connor, P. M., Daly, K. M., Hugenholtz, F., Cotter, P. D., et al. (2012). Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS ONE 7:e46884. doi: 10.1371/journal.pone.0046884
14. Gasson, M. J. (1983). Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J. Bacteriol. 154, 1-9
15. Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., et al. (2006). An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636-1637. doi: 10.1126/science.1129818
16. Helander, I. M., and Mattila-Sandholm, T. (2000). Permeability barrier of the Gram-negative bacterial outer membrane with special reference to nisin. Int. J. Food Microbiol. 60, 153-161. doi: 10.1016/S0168-1605(00)00307-X
17. Hilpert, K., Volkmer-Engert, R., Walter, T., and Hancock, R. E. W. (2005). High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23, 1008-1012. doi: 10.1038/nbt1113
18. Holo, H., and Nes, I. F. (1995). Transformation of Lactococcus by electroporation. Methods Mol. Biol. 47, 195-199. doi: 10.1385/0-89603-310-4:195
19. Hsu, S.-T. D., Breukink, E., Tischenko, E., Lutters, M. A. G., de Kruijff, B., Kaptein, R., et al. (2004). The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963-967. doi: 10.1038/nsmb830
20. Iliæ, N., Novkoviæ, M., Guida, F., Xhindoli, D., Benincasa, M., Tossi, A., et al. (2013). Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences. Biochim. Biophys. Acta 1828, 1004-1012. doi: 10.1016/j.bbamem.2012.11.017
21. Kluskens, L. D., Kuipers, A., Rink, R., de Boef, E., Fekken, S., Driessen, A. J. M., et al. (2005). Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. Biochemistry 44, 12827-12834. doi: 10.1021/bi050805p
22. Knappe, D., Piantavigna, S., Hansen, A., Mechler, A., Binas, A., Nolte, O., et al. (2010). Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. J. Med. Chem. 53, 5240-5247. doi: 10.1021/jm100378b
23. Koponen, O., Tolonen, M., Qiao, M., Wahlström, G., Helin, J., and Saris, P. E. J. (2002). NisB is required for the dehydration and NisC for the lanthionine formation in the post-translational modification of nisin. Microbiol. Read. Engl. 148, 3561-3568. doi: 10.1099/00221287-148-11-3561
24. Kuipers, A., de Boef, E., Rink, R., Fekken, S., Kluskens, L. D., Driessen, A. J. M., et al. (2004). NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. J. Biol. Chem. 279, 22176-22182. doi: 10.1074/jbc.M312789200
25. Kuipers, O. P., Beerthuyzen, M. M., Siezen, R. J., and de Vos, W. M. (1993). Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur. J. Biochem. 216, 281-291
26. Kuipers, O. P., de Ruyter, P. G., Kleerebezem, M., and de Vos, W. M. (1997). Controlled overproduction of proteins by lactic acid bacteria. Trends Biotechnol. 15, 135-140. doi: 10.1016/S0167-7799(97)01029-9
27. Li, W.-F., Ma, G.-X., and Zhou, X.-X. (2006). Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action. Peptides 27, 2350-2359. doi: 10.1016/j.peptides.2006.03.016
28. Lipinska, B., Zylicz, M., and Georgopoulos, C. (1990). The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J. Bacteriol. 172, 1791-1797
29. Lubelski, J., Rink, R., Khusainov, R., Moll, G. N., and Kuipers, O. P. (2008). Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell. Mol. Life Sci. 65, 455-476. doi: 10.1007/s00018-007-7171-2
30. Majchrzykiewicz, J. A., Lubelski, J., Moll, G. N., Kuipers, A., Bijlsma, J. J. E., Kuipers, O. P., et al. (2010). Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the Class I nisin synthetic machinery and leader sequence. Antimicrob. Agents Chemother. 54, 1498-1505. doi: 10.1128/AAC.00883-09
31. Montalbán-López, M., Zhou, L., Buivydas, A., van Heel, A. J., and Kuipers, O. P. (2012). Increasing the success rate of lantibiotic drug discovery by Synthetic Biology. Expert Opin. Drug Discov. 7, 695-709. doi: 10.1517/17460441.2012.693476
32. Naghmouchi, K., Baah, J., Hober, D., Jouy, E., Rubrecht, C., Sané, F., et al. (2013). Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob. Agents Chemother. 57, 2719-2725. doi: 10.1128/AAC.02328-12
33. Ortega, M. A., Hao, Y., Zhang, Q., Walker, M. C., van der Donk, W. A., and Nair, S. K. (2015). Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB. Nature 517, 509-512. doi: 10.1038/nature13888
34. Plat, A., Kuipers, A., Rink, R., and Moll, G. N. (2013). Mechanistic aspects of lanthipeptide leaders. Curr. Protein Pept. Sci. 14, 85-96. doi: 10.2174/1389203711314020001
35. Rink, R., Kluskens, L. D., Kuipers, A., Driessen, A. J. M., Kuipers, O. P., and Moll, G. N. (2007a). NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed nonlantibiotic peptides. Biochemistry 46, 13179-13189. doi: 10.1021/bi700106z
36. Rink, R., Kuipers, A., de Boef, E., Leenhouts, K. J., Driessen, A. J. M., Moll, G. N., et al. (2005). Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochemistry 44, 8873-8882. doi: 10.1021/bi050081h
37. Rink, R., Wierenga, J., Kuipers, A., Kluskens, L. D., Driessen, A. J. M., Kuipers, O. P., et al. (2007b). Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl. Environ. Microbiol. 73, 5809-5816. doi: 10.1128/AEM.01104-07
38. Sainath Rao, S., Mohan, K. V. K., and Atreya, C. D. (2013). A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa. PLoS ONE 8:e56081. doi: 10.1371/journal.pone.0056081
39. Sambrook, J., and Russell, D. W. (2001). Molecular Cloning: A Laboratory Manual, 3rd Edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
40. Schägger, H. (2006). Tricine-SDS-PAGE. Nat. Protoc. 1, 16-22. doi: 10.1038/nprot.2006.4
41. Torcato, I. M., Huang, Y.-H., Franquelim, H. G., Gaspar, D., Craik, D. J., Castanho, M. A., et al. (2013). Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria. Biochim. Biophys. Acta 1828, 944-955. doi: 10.1016/j.bbamem.2012.12.002
42. van der Meer, J. R., Polman, J., Beerthuyzen, M. M., Siezen, R. J., Kuipers, O. P., and de Vos, W. M. (1993). Characterization of the Lactococcus lactis nisin A operon genes nisP, encoding a subtilisin-like serine protease involved in precursor processing, and nisR, encoding a regulatory protein involved in nisin biosynthesis. J. Bacteriol. 175, 2578-2588
43. van de Ven, F. J., van den Hooven, H. W., Konings, R. N., and Hilbers, C. W. (1991). NMR studies of lantibiotics. The structure of nisin in aqueous solution. Eur. J. Biochem. FEBS 202, 1181-1188
44. van Heel, A. J., Mu, D., Montalbán-López, M., Hendriks, D., and Kuipers, O. P. (2013). Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes. ACS Synth. Biol. 2, 397-404. doi: 10.1021/sb3001084
45. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008. doi: 10.1073/pnas.97.24.13003
46. Willey, J. M., and van der Donk, W. A. (2007). Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61, 477-501. doi: 10.1146/annurev.micro.61.080706.093501
47. Yuan, J., Zhang, Z.-Z., Chen, X.-Z., Yang, W., and Huan, L.-D. (2004). Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl. Microbiol. Biotechnol. 64, 806-815. doi: 10.1007/s00253-004-1599-1
48. Zhou, L., van Heel, A. J., and Kuipers, O. P. (2015). The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity. Front. Microbiol. 6:11. doi: 10.3389/fmicb.2015.00011